{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:38:14Z","timestamp":1784860694469,"version":"3.55.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"DOI":"10.1002\/ejhf.2780","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T03:11:33Z","timestamp":1674529893000},"page":"386-388","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The \u03b23-Adrenoreceptor Agonist Mirabegron for the Treatment of Combined Pre- and Post-Capillary Pulmonary Hypertension: New Pathway or Dead End?"],"prefix":"10.1093","volume":"25","author":[{"given":"Micha T.","family":"Maeder","sequence":"first","affiliation":[{"name":"Cardiology Department, Kantonsspital St. Gallen , St. Gallen ,","place":["Switzerland"]},{"name":"University of Basel , Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"2026010913120335900_ejhf2780-bib-0001","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ejhf.2387","article-title":"Selexipag and the pulmonary hypertension continuum","volume":"24","author":"Maeder","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026010913120335900_ejhf2780-bib-0002","article-title":"Diagnosing heart failure with preserved ejection fraction with pulmonary vascular disease","author":"Maeder","year":"2022","journal-title":"Heart"},{"key":"2026010913120335900_ejhf2780-bib-0003","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01886-2017","article-title":"Macitentan in pulmonary hypertension due to left ventricular dysfunction","volume":"51","author":"Vachiery","year":"2018","journal-title":"Eur Respir J"},{"key":"2026010913120335900_ejhf2780-bib-0004","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study","volume":"124","author":"Guazzi","year":"2011","journal-title":"Circulation"},{"key":"2026010913120335900_ejhf2780-bib-0005","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurheartj\/ehx700","article-title":"Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial","volume":"39","author":"Bermejo","year":"2018","journal-title":"Eur Heart J"},{"key":"2026010913120335900_ejhf2780-bib-0006","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1093\/eurheartj\/ehac389","article-title":"Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial","volume":"43","author":"Dachs","year":"2022","journal-title":"Eur Heart J"},{"key":"2026010913120335900_ejhf2780-bib-0007","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/eurheartj\/ehv336","article-title":"Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial","volume":"36","author":"Hoendermis","year":"2015","journal-title":"Eur Heart J"},{"key":"2026010913120335900_ejhf2780-bib-0008","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ejhf.2745","article-title":"\u03b23 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial","volume":"25","author":"Garcia-Alvarez","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026010913120335900_ejhf2780-bib-0009","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009685","article-title":"Not all beta-receptors appear the same in heart failure: emergence of \u03b23-agonists as a therapeutic option","volume":"15","author":"Roy","year":"2022","journal-title":"Circ Heart Fail"},{"key":"2026010913120335900_ejhf2780-bib-0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00395-016-0567-0","article-title":"Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension","volume":"111","author":"Garcia-Alvarez","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"2026010913120335900_ejhf2780-bib-0011","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"key":"2026010913120335900_ejhf2780-bib-0012","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009120","article-title":"Hemodynamic effects of cyclic guanosine monophosphate-dependent signaling through \u03b23 adrenoceptor stimulation in patients with advanced heart failure: a randomized invasive clinical trial","volume":"15","author":"Bundgaard","year":"2022","journal-title":"Circ Heart Fail"},{"key":"2026010913120335900_ejhf2780-bib-0013","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ejhf.714","article-title":"The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial","volume":"19","author":"Bundgaard","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026010913120335900_ejhf2780-bib-0014","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2026010913120335900_ejhf2780-bib-0015","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/CIRCULATIONAHA.120.052503","article-title":"Empagliflozin effects on pulmonary artery pressure in patients with heart failure: results from the EMBRACE-HF trial","volume":"143","author":"Nassif","year":"2021","journal-title":"Circulation"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ejhf.2780","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ejhf.2780","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/25\/3\/386\/65552410\/eurjhf_25_3_386.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/25\/3\/386\/65552410\/eurjhf_25_3_386.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:15:06Z","timestamp":1767982506000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/25\/3\/386\/8343599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2,1]]},"published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.2780","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3]]},"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"2023-01-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}